ProCE Banner Activity

Fractionated Dosing Optimizes CAR T-Cell Therapy in Adult Relapsed/Refractory ALL

Slideset Download
Conference Coverage
Fractionated dosing of CTL019 minimized CRS-related toxicity and maintained high response rates in patients with relapsed/refractory CD19+ ALL.

Released: June 06, 2016

Expiration: June 05, 2017

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Ariad

Bayer Healthcare Pharma

Celgene

Genentech Roche Virology

Incyte

Merck Oncology

Taiho Pharmaceuticals